But the Phase 2 curve suggests total weight loss could reach 20 to 25% of body weight at peak effect for the highest dose group
This suppression is reversible but can persist for 24 weeks after discontinuation depending on dose and duration
Tara *Based on internal survey 416 GLP-1 users in 2025 **Based on survey responses of 166 participants in a 6-month clinical trial who had overweight or obesity, and were taking semaglutide/tirzepatide for weight loss within the WW Clinic Program and participating in the GLP-1 companion nutrition program
Companies that strengthen quality systems, review promotional activities, verify supply chain integrity, and maintain robust regulatory oversight will be best positioned to: Reduce enforcement risks Maintain operational continuity Protect patient safety Improve inspection readiness Support long-term business success As FDA scrutiny continues increasing across compounded therapeutics and digital healthcare models, strategic compliance planning will remain essential

Email address *Required Password *Required Researcher type * Select Academic / University Commercial / Industrial Laboratory Clinical Research Organization Independent Researcher Laboratory / company / institution * Intended research purpose * I certify that I am at least 21 years old and a qualified researcher, and that all products are acquired strictly for laboratory research use only not for human or animal consumption, and not for therapeutic, clinical, diagnostic, dietary supplementation, dosing, injection, ingestion, or administration use of any kind